Boston ScientificBSX

NYSE · USA · Segment 7 of 8 in the Medicine, pharma & life science value chain: Medtech & devices

Cardiology drives the growth, particularly electrophysiology, where Farapulse sits, and structural heart treatment. Endoscopy and urology cover the rest of the range.

Medtech & devices: Medical equipment and devices, from surgery and cardiology to robotics.

Key metrics

Market cap

$75B

Price

$49.01

Today

−2.7%

Return YTD

−47.2%

Return 1Y

−52.1%

P/E

20.4

P/S

3.6

P/B

3.0

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

MedtechCardiologyElectrophysiology

In the value chain

Products & services

Electrophysiology (Farapulse)
Structural heart
Endoscopy & urology

Competitors

Risks

Competition in electrophysiology
Acquisition integration

Supply chain

Supplies →

Cardinal HealthCAH

Full supply chain for BSX →

Same segment: Medtech & devices

Intuitive SurgicalISRG StrykerSYK MedtronicMDT Edwards LifesciencesEW Becton DickinsonBDX GE HealthCareGEHC ResMedRMD Zimmer BiometZBH

Compare BSX

BSX vs ISRG BSX vs SYK BSX vs MDT BSX vs EW BSX vs BDX BSX vs GEHC

See where Boston Scientific sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →